Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$550.72 USD

550.72
463,800

+3.25 (0.59%)

Updated Aug 27, 2024 04:00 PM ET

After-Market: $551.01 +0.29 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (170 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Why Earnings Season Could Be Great for McKesson (MCK)

by Zacks Equity Research

McKesson (MCK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Uber (UBER) to Report Q4 Earnings: What's in the Offing?

by Zacks Equity Research

Higher ridesharing revenues are likely to have boosted Uber's (UBER) top line in fourth-quarter 2019.

What's in Store for Cardinal Health's (CAH) Q2 Earnings?

by Zacks Equity Research

Cardinal Health (CAH) fiscal second-quarter earnings are likely to reflect better-than-expected performance at Pharmaceutical and Medical segments.

Cerner (CERN) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Top-line growth and solid show by Population Health, Revenue Cycle and IT Works are likely to have aided Cerner's (CERN) Q4 earnings. However, contraction in gross margin is likely to have been a dampener.

McKesson (MCK) to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research

McKesson's (MCK) core U.S. Pharmaceutical and Specialty Solutions unit is expected to reflect in fiscal Q3 results.

MCK vs. ALGN: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

MCK vs. ALGN: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: McKesson, Chipotle Mexican Grill, Microchip Technology, Kellogg and CDW

by Zacks Equity Research

The Zacks Analyst Blog Highlights: McKesson, Chipotle Mexican Grill, Microchip Technology, Kellogg and CDW

McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nalak Das headshot

6 Top Large-Cap Stocks Set to Soar on Earnings Next Week

by Nalak Das

In line with improving earnings results, six large-cap stocks are poised to beat earnings estimates next week.

The Zacks Analyst Blog Highlights: Alphabet, salesforce.com, L3Harris, McKesson and Synopsys

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Alphabet, salesforce.com, L3Harris, McKesson and Synopsys

Is McKesson (MCK) a Profitable Stock for Value Investors?

by Zacks Equity Research

McKesson (MCK) is a good value-oriented pick for investors from all angles.

Nalak Das headshot

Buy 6 Top-Ranked Surging S&P 500 Stocks to Gain More in 2020

by Nalak Das

Several large-cap stocks within the index have already popped more than 10% year to date and still have strong upside left.

Will McKesson Continue to Surge Higher?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in McKesson.

Dentsply (XRAY) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Dentsply (XRAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Sanghamitra Saha headshot

S&P 500 Up 1000 Points in a Month: 10 Stocks Boosted the ETF

by Sanghamitra Saha

The S&P 500 touched the 3,300 mark on Jan 16, having added 1000 points in less than a month. Which stocks led to the ETF rally.

Sweta Killa headshot

10 Top-Ranked S&P 500 Stocks Outperforming in 2020

by Sweta Killa

The rally has been broad based and there are winners across various corners of the space.

Is McKesson (MCK) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The Zacks Analyst Blog Highlights: Estee Lauder, Bank of New York ??? Mellon, Canadian Pacific Railway, McKesson and Ameriprise Financial

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Estee Lauder, Bank of New York ??? Mellon, Canadian Pacific Railway, McKesson and Ameriprise Financial

Mark Vickery headshot

Top Stock Reports for Estee Lauder, BNY Mellon & Canadian Pacific Railway

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Estee Lauder (EL), Bank of New York Mellon (BK) and Canadian Pacific Railway (CP).

MCK vs. ALGN: Which Stock Is the Better Value Option?

by Zacks Equity Research

MCK vs. ALGN: Which Stock Is the Better Value Option?

McKesson, Walgreens Form JV for European Pharmaceutical Unit

by Zacks Equity Research

The VA selects McKesson (MCK) as their prime pharmaceutical supplier.

Sreyoshi Mukherjee headshot

SaMD Drives All Facets of US Healthcare: 3 Stocks to Watch

by Sreyoshi Mukherjee

As IoT slowly takes over the healthcare fraternity, let's take a look at three stocks which might prove to be profitable investment options over the long run.

Kinjel Shah headshot

Fed Reportedly Opens Criminal Investigation on Opioid Makers

by Kinjel Shah

Shares of some manufacturers and distributors of opioid drugs decline on Tuesday following reports that a criminal probe has been initiated by federal prosecutors.

Here's Why You Should Retain McKesson (MCK) Stock for Now

by Zacks Equity Research

McKesson (MCK) is gaining from strong segmental performance and solid prospects in the pharmaceutical and medical supplies distribution market. However, rising pricing pressure remains a concern.

McKesson (MCK) Q2 Earnings Meet Estimates, Revenues Beat

by Zacks Equity Research

McKesson's (MCK) Q2 results gain from higher revenues and solid show by U.S. Pharmaceutical and Specialty, and Medical-Surgical Solutions.